You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (8) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (9) Apply Biologicals filter
- Blood and blood components (4) Apply Blood and blood components filter
- Complementary medicines (22) Apply Complementary medicines filter
- Cosmetics (2) Apply Cosmetics filter
- Disinfectants/Sterilants (4) Apply Disinfectants/Sterilants filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (23) Apply Labelling/Packaging filter
- Legislation (20) Apply Legislation filter
- Remove Listed medicines filter Listed medicines (2)
- Manufacturing (11) Apply Manufacturing filter
- Medical devices safety (1) Apply Medical devices safety filter
- Medical devices/IVDs (48) Apply Medical devices/IVDs filter
- Medicinal cannabis (1) Apply Medicinal cannabis filter
- Medicines (1) Apply Medicines filter
- Remove OTC medicines filter OTC medicines (31)
- Prescription medicines (25) Apply Prescription medicines filter
- Safety of medicines & medical devices (2) Apply Safety of medicines & medical devices filter
- Scheduling (37) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (6) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (6) Apply Therapeutic goods regulation filter
Changes to permissible ingredients - Low-negligible risk
Closed on 11 October 2019
Benzocaine: proposed advisory statements for medicines
Closed on 16 October 2018
Options for the implementation of a claimer for efficacy assessed non-prescription medicines
Closed on 21 June 2018
Paracetamol and ibuprofen: advisory statements for medicines
Closed on 22 November 2016
Non-steroidal anti-inflammatory drugs: proposed additional advisory statement
Closed on 22 November 2016
cimetidine, famotidine, nizatidine and ranitidine: corrected advisory statement for medicines
Closed on 29 October 2015
Draft OTC medicine monographs for Bromhexine hydrochloride; Dextromethorphan hydrobromide; Laxatives: Docusate sodium and/or sennosides; Hand sanitisers
Closed on 11 June 2015
Metoclopramide: proposed advisory statements for medicines
Closed on 7 April 2015
Non-steroidal anti-inflammatory drugs (diclofenac, flurbiprofen, ibuprofen, ketoprofen, mefenamic acid and naproxen) for oral use: proposed additional advisory statements for medicines
Closed on 18 March 2015
Review of cardiovascular safety of non-steroidal anti-inflammatory drugs and Safety review of diclofenac
Closed on 6 November 2014